Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print

Features

Related Searches: Outsourcing Aseptic CDMO pharma companies
Contract Pharma’s 15th Anniversary Retrospective: Then & Now
Kristin Brooks, Contract Pharma
October 14, 2014
A look back at the pharma/biopharma industry and outsourcing.  Read More »
Contamination Issues in Today’s Injectables Market
Bill Hartzel , Director, Strategic Execution, Advanced Delivery Technologies
October 14, 2014
BFS technology drives advances in aseptic processing.  Read More »
CROs Are Front and Center in Strategic Innovation Partnerships
Dr. MaryAnne Rizk , Oracle Health Sciences
October 14, 2014
New data is fueling the drug development pipeline.  Read More »
Agile Drug Development: Lessons from the Software Industry
Pedram Alaedini, Birnur Ozbas PhD, and Fahri Akdemir, Primapax and C1 Consulting
October 14, 2014
Why pharma needs to move from a “waterfall” to a “scrum” model  Read More »
The Nuances of Branded Rx Drug Fee Regulations
Alice Valder Curran, John S. Stanton and Andrew S. Furlow , Hogan Lovells
October 14, 2014
Final ACA revisions and clarifications: a drug manufacturers guide  Read More »
Preparing for the End
Lonie Scott , Director of Clinical Business Development for North America, PCI
October 14, 2014
Keep sight of return logistics as you prepare for clinical trials.  Read More »
Using Microscopical Analysis Methods
Gretchen Shearer , Senior Research Chemist, McCrone Associates, Inc.
October 14, 2014
The integrity of the container system is crucial to the safety of parenteral products.  Read More »
Newsmakers: Cell Therapies Look to Change the Paradigm of Drug Products
Kristin Brooks, Associate Editor
October 14, 2014
While expensive and difficult to produce, Big Pharma is investing, looking to overcome the obstacles to development and commercialization that remain  Read More »
Kristin Brooks, Associate Editor
October 14, 2014
Patheon’s Biologics Unit makes its foray into the U.S. market with Gallus Acquisition  Read More »
A Blueprint for Improved Pharma Competitiveness
Girish Malhotra , Epcot International
September 8, 2014
Change could increase profits and revenues, but it will come from without, not within, the industry  Read More »
Agnes Shanley , Editor
September 8, 2014
Research suggests that the most effective corporate programs support business strategy, and are closely linked to risk and quality management.  Read More »
Risk and Quality Management: Connecting the Dots
Bikash Chatterjee , President and CTO, Pharmatech
September 8, 2014
A brief review of pharma’s new thinking regarding quality and risk management, and key risk management tools  Read More »
Robert Dodd, Aloft Aviation Consulting
September 8, 2014
Where FMEA, fault tree and other risk management methods drill down to the tiniest detail, Bow Tie methods allow for a broader view of risk throughout the enterprise.  Read More »
Taking a Proactive Approach to Patient Safety Monitoring
Dr. Chitra Lele , Chief Scientific Officer, Sciformix Corporation
September 8, 2014
Stringent pharmacovigilance standards are needed during drug development and post-approval stages.  Read More »
Clinical Trial Supplies 101: An Outsourcing Primer for Virtual Pharma and Biopharma Companies, Part1
Joseph Iacobucci and Damian Gant , Clinical Supplies and Xcelience
September 8, 2014
Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. Outsourcing makes the process even more complex. This series of articles presents tips on how to do it right.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On